Quantcast

Latest Clinical cardiac electrophysiology Stories

2011-03-07 14:17:39

New stretchable electronics device promises to make cardiac ablation therapy simpler In an improvement over open-heart surgery, cardiologists now use catheters to eliminate damaged heart tissue in certain patients, such as those with arrhythmias. But this, too, can be a long and painful procedure as many catheters, with different functions, need to be inserted sequentially. Now an interdisciplinary team including researchers from Northwestern University has developed one catheter that can do...

2011-02-24 07:00:00

SANTA CLARA, Calif., Feb. 24, 2011 /PRNewswire/ -- PR Newswire - NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiovascular diagnostic solutions developer, announced today that the Company has been invited by the Heart Rhythm Society (HRS) to present results of a recent clinical study showing that recurrent atrial fibrillation (AF) was accurately and timely detected in patients who used CardioBip(TM) for daily monitoring following catheter ablation procedures. The presentation, entitled...

2011-01-10 07:03:00

MORRISVILLE, N.C., Jan. 10, 2011 /PRNewswire/ -- nContact Surgical, Inc. (nContact), a cardiac ablation device manufacturer, announced today that it is changing the name under which it operates from nContact Surgical, Inc. to nContact, Inc. As the pioneer of interdisciplinary epicardial and endocardial cardiac ablation, the change represents the Company's further evolution towards closed chest approaches to treating common cardiac arrhythmias. "nContact's progressive technology and our...

2010-11-10 07:30:00

MORRISVILLE, N.C., Nov. 10, 2010 /PRNewswire/ -- nContact Surgical, Inc. (nContact), a cardiac ablation device manufacturer, announced today that it has closed a $16 million Series D round of equity financing, bringing the company's total financing since inception to $42.4 million. The financing was led by existing investors, Harbert Venture Partners, and included new investors, ZMV Associates. The company expects this financing to support its three ongoing clinical trials, further product...

bcae1f8b3fc6d4a0bf426335afc510501
2010-11-09 08:47:39

By Rachel Champeau, UCLA New study reports on UCLA medical team's experience with new techniques New techniques now being used at UCLA allow doctors to more precisely target certain areas of the heart to stop ventricular arrhythmias "” serious abnormal rhythms in the heart's lower chambers "” in high-risk patients. Generally, arrhythmias can be controlled by medications, and sometimes defibrillators. But a potentially life-threatening, recurrent arrhythmia known as a ventricular...

2010-09-21 06:29:00

DALLAS, September 21, 2010 /PRNewswire/ -- ReportsandReports announces it will carry U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 Research Report in its store. Browse the complete Report on: http://www.reportsandreports.com/reports/34141-us-market-for-cardiac-rhythm-m anagement-electrophysiology-and-.html Search More Then 50000 Market Research Reports at ReportsandReports (http://www.reportsandreports.com/) Browse All IData Research...

2010-05-14 09:11:06

New research presented at National Heart Rhythm Society Sessions shows ablation treatment can eliminate serious risks associated with atrial fibrillation New findings by researchers from the Heart Institute at Intermountain Medical Center in Murray, Utah, reveals treatment of the most common heart rhythm disorder that affects more than two million Americans significantly reduces the risk of stroke, mortality, Alzheimer's disease and other forms of dementia. According to two new studies by the...

2010-05-13 09:36:00

DIAMOND BAR, California, May 13, 2010 /PRNewswire/ -- Biosense Webster, Inc. will underline its leadership position in the electrophysiology market and underscore its commitment to electrophysiologists and their catheter ablation practices at the 2010 Heart Rhythm Meeting. Heart Rhythm is the most important scientific meeting in the field of Electrophysiology and will be held in Denver, CO, USA from May 12th to 15th. This year, Biosense Webster, Inc. will be showcasing its cutting...

2010-05-13 06:30:00

RALEIGH, N.C., May 13 /PRNewswire/ -- nContact Surgical, Inc. (nContact) announced it has enrolled the first patient in its IDE trials to evaluate a fully closed chest procedure combining the best of Electrophysiologist (EP) catheter and surgical techniques for the treatment of atrial fibrillation (AF) using the investigational Numeris® - AF Guided Coagulation System with VisiTrax®. The three hour procedure is performed in a single setting, generally...

2010-04-21 07:48:00

WALTHAM, Mass., April 21 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, specialty radiofrequency catheters will drive growth in the European catheter market and support the use of catheter ablation as a treatment for atrial fibrillation. According to MRG's new European Markets for Electrophysiology Mapping and Ablation Devices 2010 report, specialty radiofrequency ablation catheter use will grow at a compound...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related